Wednesday, July 8, 2026

pharma · Cystic Fibrosis (CF) · Accidental Hypothermia · SION

Sionna Therapeutics

Sionna Therapeutics trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Boston, USA HQ
2019 Founded
74 Employees
Public company Type
SION · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Founded
2019
Employees
74
Programs
5
Drugs
4
Patents
0
Intelligence · Clinical Trials

Sionna Therapeutics clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to Sionna Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Sionna Therapeutics trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for Sionna Therapeutics.

  1. pad-gauze with tranexamic acid (Hemostopan™) — Phase 3

    Clinical update
  2. blood draw from three different vessels — Unknown

    Clinical update
  3. Polyamide HD membrane — Phase 3

    Clinical update
  4. SION-719 — Phase 2

    Clinical update
  5. SION-451 — Phase 1

    Clinical update

Trial registry

5 studies